Atlas Trials

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

Clinical trial NCT02404025 · COMPLETED

Trial details

NCT number
NCT02404025
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Aplastic Anemia
Start date
2015-05-12
Primary completion
2016-07-05
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.